Aeras and its own research partners.

Aeras receives grant to develop new vaccines for TB TB vaccine development receives a boostThe Aeras Global TB Vaccine Base is pleased to announce that holland Ministry of Foreign Affairs has renewed its funding to Aeras with a pledge of yet another -11 .7 million over four years to further its efforts to develop new vaccines to help fight the global epidemic of tuberculosis. This expression of support represents a continuation in the long-position collaboration between the Dutch federal government, Aeras and its own research partners. This is actually the second grant to Aeras from holland Ministry of Foreign Affairs, representing a total commitment of -30.4 million to Aeras since 2006. The forward motion of TB vaccine applicants in the development pipeline owes a great deal to the generous support of the Dutch Ministry of Foreign Affairs and the folks of the Netherlands, said Jim Connolly, President and Chief Executive Officer of the Aeras Global TB Vaccine Foundation.

Is pleased to announce that the SterilContainer S products has been cleared by america Food and Medication Administration , quantity, K093649) for use in the STERIS Corporation’s V-PRO 1 and V-PRO 1 Plus Low Heat Sterilization Systems. The Aesculap SterilContainer S can be a reusable, friendly environmentally, rigid container system used for the product packaging, transportation, and storage space of instruments to prior, during and after sterilization. The SterilContainer S products includes Full, Three Quarter, Extra and Half Very long Mini size SterilContainers, instrument baskets, filters, indicator cards, tamper proof locks, silicone mats, and the Aesculap Instrument Organization System.